
Biocon Limited has informed the Exchange about press release dated 17-Oct-2022 titled "Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan"
Filed with NSE ·

Biocon Limited has informed the Exchange about press release dated 17-Oct-2022 titled "Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan"
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon